PA
TILE icon

PharVision Advisers’s Interface TILE Stock Holding History

PharVision Advisers’s Portfolio TILE Stock Details TILE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,161
Closed -$223K – 507
2024
Q4 		$223K Buy
+9,161
New +$210K 0.19% 261

Other funds holding TILE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

PharVision Advisers's TILE Position: Q1 2025 in Review

PharVision Advisers sold out of Interface (TILE) in Q1 2025, closing a stake of 9,161 shares — an estimated $223K sold.

PharVision Advisers first reported a position in TILE in Q4 2024 and held it in 1 quarter. The position peaked at $223K in Q4 2024. 259 funds tracked by Wall St. Rank hold TILE as of Q1 2025.

  • PharVision Advisers reported no remaining Interface position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 9,161 Interface shares in Q1 2025, an estimated $223K.
  • PharVision Advisers first reported a position in Interface in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Interface position peaked at $223K in Q4 2024.
  • 259 funds tracked by Wall St. Rank held Interface as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.